Celyad - News

Corporate › Non-regulated May 26, 2020

Celyad Announces June 2020 Conference Schedule

Corporate › Non-regulated May 06, 2020

Celyad Appoints Seasoned Industry Executives to Board of Directors

Corporate › Non-regulated April 30, 2020

Celyad to Present Update from CYAD-101 for Advanced Colorectal Cancer and Next-Generation shRNA Platform at 2020 ASCO Virtual Scientific Program

Corporate › Non-regulated March 12, 2020

Celyad to Announce Full Year 2019 Financial Results and Host Conference Call

Corporate › Non-regulated March 02, 2020

Celyad Appoints Stephen Rubino as Chief Business Officer

Corporate › Non-regulated February 17, 2020

Celyad Announces February and March 2020 Conference Schedule

Corporate › Non-regulated January 13, 2020

Celyad Successfully Doses First Patient with CYAD-02 in CYCLE-1 Trial for r/r AML and MDS

Corporate › Non-regulated December 10, 2019

Celyad Presents Update on r/r AML and MDS Program at 61st ASH Annual Meeting

Corporate › Non-regulated November 22, 2019

Celyad Receives €8.5 Million in Grants and Non-Dilutive Funding by the Walloon Region

Corporate › Non-regulated October 02, 2019

Celyad Announces October and November 2019 Investor Conference Schedule

Corporate › Non-regulated August 29, 2019

Celyad to Participate in Upcoming September 2019 Conferences

Corporate › Non-regulated August 16, 2019

Celyad to Provide First Half 2019 Financial Results & Business Highlights and Host a Conference Call